Loading clinical trials...
Loading clinical trials...
Coronary allograft vasculopathy (CAV) is the leading cause of late graft failure and second leading cause of late mortality after heart transplantation. CAV has been associated with a variety of tradi...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Gladwin, Mark, MD
NCT06990711 · Antibody Mediated Rejection of Lung Transplant
NCT04770012 · Cardiac Allograft Vasculopathy, Heart Transplant
NCT02798731 · Cardiac Allograft Vasculopathy
NCT05826444 · Cardiac Allograft Vasculopathy
NCT05756088 · Cardiac Allograft Vasculopathy, Endothelial Dysfunction, and more
University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions